Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 2 Published - 14:00 UTC    08:00 EST    14-March-2001      
Issue 73 Next Update - 14:00 UTC 08:00 EST    15-March-2001      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Back To Vidyya Today In Vidyyasm

Vidyya Medical News Service For 14-March-2001:

The following stories appear in full on Today's Vidyya Medical News Service Web site.

Patients with advanced non-small cell lung cancer are often given six courses of chemotherapy, and some patients are continually treated as long as the disease is kept at bay. Now a British study, published in the 01 March 2001, issue of the Journal of Clinical Oncology, indicates that three rounds of treatment may offer the same benefit to patients as six or more.

For more information: Chemotherapy And Advanced Lung Cancer: Less Treatment May Be Enough

MacroChem Corporation announced today that it is closing enrollment of new patients into a pivotal phase 3 trial for Topiglan®, the company's topical gel that may enable tens of millions of men who cannot or will not take Viagra® on option for the treatment of erectile dysfunction ("ED"). Planned as a trial of about 400 patients, the MacroChem study attracted more than 700 couples to 30 academic and private clinics nationwide.

For more information: Topical Drug For Erectile Dysfunction Has Closed Enrollment For Phase III Study - There Were Too Many Volunteers For The Study

It's Brain Awareness Week and Vidyya presents a resource for patients and professionals on the subject of concussion and brain injury. Each year about 1.5 million Americans sustain traumatic brain injuries (TBI) in the US. Learn more about brain injury and concussion.

For more information: Facts About Concussion And Brain Injury

Hospitalizations that might have been avoided if patients had received timely and effective ambulatory care increased by two thirds from 1980-98 according to results from the Centers for Disease Control and Prevention's National Health Care Survey, published in the March-April 2001 issue of Health Affairs.

For more information: Hospital Use Down But Avoidable Hospitalizations Increase

A nationwide study sponsored by the federal Agency for Healthcare Research and Quality (AHRQ), has found that expenditures for hospital inpatient care for HIV fell more than 40 percent by  mid-1997 in the wake of the introduction early the preceding year of highly active combination antiretroviral therapy, a mixture of protease inhibitors and other drugs.  The decrease in demand for hospital care, along with a more modest reduction in the use of outpatient care, helped drive down overall treatment expenditures for HIV patients by one-sixth between early 1996 and late 1998.

For more information: Study Links New Therapies To Decline In Hospital Costs For Most, But Not All HIV Patients

Today's Vidyya articles are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 
Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.